Identification of small molecule sphingomyelin synthase inhibitors.

[1]  M. Kuo,et al.  Impact of Sphingomyelin Synthase 1 Deficiency on Sphingolipid Metabolism and Atherosclerosis in Mice , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Xiaodong Deng,et al.  Development, Validation, and Application of a Novel Method for Mammalian Sphingomyelin Synthase Activity Measurement , 2012 .

[3]  R. M. Adibhatla,et al.  Tricyclodecan-9-yl-Xanthogenate (D609) Mechanism of Actions: A Mini-Review of Literature , 2011, Neurochemical Research.

[4]  D. Peake,et al.  Reducing Plasma Membrane Sphingomyelin Increases Insulin Sensitivity , 2011, Molecular and Cellular Biology.

[5]  Renxiao Wang,et al.  Molecular Modeling of the Three-Dimensional Structure of Human Sphingomyelin Synthase , 2011 .

[6]  Xian-cheng Jiang,et al.  Sphingomyelin biosynthesis: its impact on lipid metabolism and atherosclerosis , 2009 .

[7]  J. Borén,et al.  Ira Tabas , Kevin Jon Williams and Jan Borén and Therapeutic Implications Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis : Update , 2007 .

[8]  T. Lübbers,et al.  Design, synthesis, and structure-activity relationship studies of new phenolic DNA gyrase inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[9]  Jibin Dong,et al.  Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice Published, JLR Papers in Press, February 28, 2006. , 2006, Journal of Lipid Research.

[10]  M. Hojjati,et al.  Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice. , 2005, Biochimica et biophysica acta.

[11]  Y. Hannun,et al.  Prodrug Modification Increases Potassium Tricyclo[5.2.1.02,6]-decan-8-yl Dithiocarbonate (D609) Chemical Stability and Cytotoxicity against U937 Leukemia Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.

[12]  Y. Hannun,et al.  Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells. , 2004, Experimental cell research.

[13]  J. Brouwers,et al.  Identification of a family of animal sphingomyelin synthases , 2004, The EMBO journal.

[14]  F. Himo,et al.  Mechanisms of tetrazole formation by addition of azide to nitriles. , 2002, Journal of the American Chemical Society.

[15]  T. Tsuruo,et al.  P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel , 2002, Cancer Chemotherapy and Pharmacology.

[16]  M. Tatsumi,et al.  Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  Urtiaga,et al.  A convenient strategy for the synthesis of 4,5-bis(o-haloaryl)isoxazoles , 2000, The Journal of organic chemistry.

[18]  M. Kanai,et al.  A Catalytic Asymmetric Strecker‐Type Reaction: Interesting Reactivity Difference between TMSCN and HCN , 2000 .

[19]  A. Davies,et al.  A Facile Synthesis of Substituted Phenylglycines , 2000 .